deepGeneAI

DeepGene is a precision medicine company that leverages artificial intelligence and high-throughput sequencing to revolutionize cancer screening and clinical diagnosis. The company's core technology, the DeepGene AI platform, utilizes advanced deep learning models to analyze complex genomic data, including somatic point mutations and gene expression profiles, for accurate tumor subtyping and biomarker discovery. DeepGene offers a suite of diagnostic products, such as DeepGene-Onco, which provide clinicians with actionable insights for personalized therapy selection. Beyond diagnostics, the company is expanding its AI capabilities into drug discovery and infectious disease monitoring, aiming to bridge the gap between genomic data and clinical outcomes. Headquartered in Beijing, DeepGene is backed by prominent venture capital firms and collaborates with leading medical institutions to advance AI-driven healthcare.